Response to selpercatinib in a patient with <i>RET</i> fusion-positive pulmonary large-cell neuroendocrine carcinoma: A case report.

Arora, Aakriti; Zaemes, Jacob; Ozdemirli, Metin; Kim, Chul

Response to selpercatinib in a patient with RET fusion-positive pulmonary large-cell neuroendocrine carcinoma: A case report.

Arora, Aakriti; Zaemes, Jacob; Ozdemirli, Metin; Kim, Chul.

Afiliación

Arora A; Department of Medicine, MedStar Washington Hospital Center, Washington, DC, United States.
Zaemes J; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States.
Ozdemirli M; Department of Pathology, MedStar Georgetown University Hospital, Washington, DC, United States.
Kim C; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States.

Front Oncol ; 13: 1134151, 2023.

Article en En | MEDLINE | ID: mdl-36998440

Palabras clave

RET fusion; large cell neuroendocrine carcinoma; lung cancer (LC); selpercatinib; targeted

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google